"Liver monitoring is mandatory" is the most repeated warning around Fenbendazole — but what does the actual evidence behind it show? This guide breaks down a published 2026 case report of Fenbendazole-related liver injury, the CYP450 mechanism that explains why it happens, the specific dosing pattern linked to harm, and the exact monitoring schedule recommended in the safety literature.

Fenbendazole, Mebendazole, and Albendazole are often mentioned together in repurposed-drug cancer research — but they are not the same drug. All three belong to the benzimidazole family and share a core mechanism, yet differ sharply in human approval status, cancer research evidence, cost, and safety profile. This guide breaks down exactly how they compare, side by side.